BRAMBILLA, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 599
EU - Europa 213
AS - Asia 30
SA - Sud America 1
Totale 843
Nazione #
US - Stati Uniti d'America 594
IE - Irlanda 134
IT - Italia 42
SG - Singapore 20
BE - Belgio 12
DE - Germania 11
CA - Canada 5
CH - Svizzera 4
AT - Austria 3
GB - Regno Unito 3
IN - India 3
JP - Giappone 3
FI - Finlandia 2
MY - Malesia 2
ES - Italia 1
IR - Iran 1
PE - Perù 1
SE - Svezia 1
TH - Thailandia 1
Totale 843
Città #
Chandler 203
Dublin 134
Ashburn 45
Boardman 37
Princeton 31
Lawrence 30
Wilmington 30
Medford 23
Ann Arbor 12
Brussels 12
Milan 10
Singapore 9
Chicago 7
New York 6
Munich 5
Los Angeles 4
Padova 4
Seattle 4
Toronto 4
Bengaluru 3
Bielefeld 3
Des Moines 3
Falls Church 3
Ferrara 3
Florence 3
Limbiate 3
Norwalk 3
Pavia 3
Washington 3
Cardiff 2
Fairfield 2
Geneva 2
Helsinki 2
Piemonte 2
Saccolongo 2
Turin 2
Vienna 2
Atlanta 1
Bang Sue 1
Buffalo 1
Cagliari 1
Camden 1
Catanzaro 1
Dallas 1
Frankfurt am Main 1
Geislingen an der Steige 1
Genoa 1
Henderson 1
Lima 1
Lugano 1
Málaga 1
Palermo 1
Rome 1
Santa Clara 1
Zanjan 1
Zurich 1
Totale 675
Nome #
Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders 45
Neuroprotective peptide 39
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin 39
Therapeutic for treating neuropsychiatric disorders or conditions 34
Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies 34
Editorial 33
Impairment of cocaine-mediated behaviours in mice by clinically relevant ras-ERK inhibitors 32
Lentiviral Vectors as Research Tools in Neurobiology: Design and Production 31
Neuronal signaling and behavior 30
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia 29
Behavioral Methods for the Study of Ras-ERK Pathway in Memory Formation and Consolidation: Passive Avoidance and Object Recognition Tests 28
Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis 27
Viral Vector Approaches in Neurobiology and Brain Diseases”, Neuromethods (Humana Press, Springer) 27
Increased lipolysis and altered lipid homeostasis protect γ-synuclein-null mutant mice from diet-induced obesity 25
Dopamine D1 and Glutamate Receptors Co-operate With Brain-Derived Neurotrophic Factor (BDNF) and TrkB to Modulate ERK Signaling in Adult Striatal Slices 24
Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum 24
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control 24
Understanding cognitive deficits in Parkinson's disease: Lessons from preclinical animal models 23
Derangement of ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-Induced dyskinesia 23
The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice 23
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 23
Synaptic GluN2B/CaMKII-α signaling induces synapto-nuclear transport of ERK and jacob 23
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy 22
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 22
A rational design of α-helix-shaped peptides employing the hydrogen-bond surrogate approach: A modulation strategy for ras-rasgrf1 interaction in neuropsychiatric disorders 22
Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family 21
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 20
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia 20
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice 17
Phosphorylation of Parkin at serine 65 is essential for its activation in vivo 17
Pharmacological inhibition of ERK signaling rescues pathophysiology and behavioral phenotype associated with 16p11.2 chromosomal deletion in mice 17
Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy 15
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders 13
Dissecting the autism-associated 16p11.2 locus identifies multiple drivers in neuroanatomical phenotypes and unveils a male-specific role for the major vault protein 9
Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes 8
Gut-muscle-brain axis: Molecular mechanisms in neurodegenerative disorders and potential therapeutic efficacy of probiotic supplementation coupled with exercise 8
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2 7
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias 5
Totale 883
Categoria #
all - tutte 5.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 32 5 0 0 0 0
2021/2022133 0 0 5 0 7 2 2 16 15 3 16 67
2022/2023469 44 54 4 53 44 49 0 22 171 2 16 10
2023/2024157 19 10 4 13 25 42 9 5 1 9 5 15
2024/202587 17 46 22 2 0 0 0 0 0 0 0 0
Totale 883